Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» V920
V920
Merck's Ebola vaccine tees up FDA date, aiming for first status
Fierce Biotech
Tue, 09/17/19 - 10:16 am
Merck
ebola virus
vaccines
FDA
V920
HHS pledges $23M to develop Merck's experimental Ebola vaccine
Beckers Hospital Review
Fri, 08/23/19 - 10:19 am
HHS
vaccines
Merck
V920
ebola virus